© PLID
The Paul Langerhans Institute Dresden
Over the last few decades, diabetes mellitus has developed into an epidemic dimension. More and more people around the world suffer from this metabolic disease and its consequences, and even children and young people in the industrial nations are increasingly affected.
The Paul Langerhans Institute of the Helmholtz Zentrum München at the University Hospital Carl Gustav Carus and the Medical Faculty of TU Dresden (PLID) contributes decisively to a better understanding of the mechanisms of the disease and to explore new therapeutic options. The institute is a founding-partner of the German Center for Diabetes Research (DZD e.V.) and has been a satellite institute of the Helmholtz Zentrum München since January 2015. Working in the DZD network allows research projects of a much larger scale, both in the area of basic research through interdisciplinary approaches as well as in the area of clinical studies.
With the founding of the DZD in 2009, the German government created a national research association which aims to bring research results more quickly to clinical practice. To this end, it brings together experts in the field of diabetes research, so that basic research, epidemiology, translational research and clinical application can closely interact and successful research as well as effective prevention and treatment measures can be realized.
You will find more information about our scientific work under Research.
© PLID
Institute Administration
Send encrypted mail via the SecureMail portal (for TUD external users only).
Visiting address:
Paul Langerhans Institut Dresden Tatzberg 47 / 49
01307 Dresden
Postal address:
Technische Universität Dresden Paul Langerhans Institut Dresden Fetscherstraße 74
01307 Dresden
The upcoming DZD workshop will take place in Dresden on October 11/12, 2022 and is organized by Michele Solimena and his team at the PLID. This time, the focus lies on two topics:
- Organ cross talk in the pathophysiology of diabetes is highlighted by the Prevention of Type 2 Diabetes and Complications of Diabetes Academies.
- Beta Cell – Immune Cell Interaction in Type 1 Diabetes is presented as common topic of the Beta Cell and Pancreatic Islet Protection and Regeneration and Prevention and Pathogenesis of Type 1 Diabetes Academies.
Moreover, short talks and posters will provide an overview on the latest results and exciting projects.
How does our body process sugar and what goes wrong in people with diabetes? What is the role of insulin from the pancreas and how are other organs, muscles and the brain involved in sugar metabolism? © HelmholtzZentrum München
